Sebi fines Biocon, its designated person for violating market norms

Markets regulator Sebi on Wednesday imposed a total fine of Rs 14 lakh on Biocon Ltd and its designated person for violation of market norms.

Sebi
Press Trust of India New Delhi
2 min read Last Updated : May 19 2021 | 8:40 PM IST

Markets regulator Sebi on Wednesday imposed a total fine of Rs 14 lakh on Biocon Ltd and its designated person for violation of market norms.

Designated person of the firm, Narendra Chirmule, who was employed with the company as senior vice president-R&D is facing a fine of Rs 5 lakh for trading in the company's securities when the trading window was closed.

By doing so, he violated provisions of Prohibition of Insider Trading (PIT) norms.

Sebi noted that the trading window was closed by the compliance officer of Biocon from January 1-26, 2019 on account of declaration of quarterly financial results of the company for the quarter ended December 31, 2018, which were announced on January 24, 2019.

In accordance with market norms, the company has to notify the particulars of the trading details of the promoter / member of the promoter group /designated person /director, if the value of the securities traded is in excess of Rs 10 lakh, to the stock exchange within 2 trading days of receipt of the disclosure or from becoming aware of such information.

However, Biocon had informed the bourses after a delay of 262 days.

In addition, market norms require that violation of code of conduct (CoC) be informed to the regulator "promptly."

Biocon informed Sebi after 28 days of becoming aware of violation of company's code of conduct.

In violation of norms, the company did not define the deadline for informing the violation of PIT Regulations.

"It is noted that the company had failed to prescribe any deadline within which it is required to inform Sebi of the violation of CoC," the regulator said.

The information which was made belatedly by the company cannot be construed to be a reasonable period, it added.

Consequently, Biocon is facing a total penalty of Rs 9 lakh for violating various provisions of PIT norms.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :SEBIBioconMarkets

First Published: May 19 2021 | 8:29 PM IST

Next Story